Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain.
In this work, the molecular forms of the rat neurotensin receptor (NTR) expressed in transfected Chinese hamster ovary (CHO) cells, in infected Sf9 insect cells and in rat cerebral cortex were immunologically detected by means of an anti-peptide antibody raised against a fragment of the third intracellular loop of the receptor. Immunoblot experiments against a fusion protein indicated that the anti-peptide antibody recognized, under denaturing conditions, the corresponding amino acid sequence within the NTR. In immunoblot analysis of membranes from NTR-transfected CHO cells, high levels of immunoreactivity were observed between 60 and 72 kDa, while only a faint labelling was observed at 47 kDa, the molecular mass deduced for the rat NTR cDNA. The bands of high molecular mass were no longer observed after deglycosylation of membrane proteins by peptide N-glycosidase F, indicating that they represented glycosylated forms of the receptor. Extracts of membranes derived from baculovirus-infected Sf9 insect-cells expressing the NTR provided a quite different immunoblot pattern, since the major band detected in that case was at 47 kDa, the molecular size of the non-glycosylated receptor. Taken together, these data show that, while most of the NTR protein was glycosylated in CHO cells, it was unglycosylated in Sf9 insect-cells. In addition, molecular sizes of the receptor proteins observed in these two cell lines differed from those obtained for the NTR endogenously expressed in the rat cerebral cortex of 7 day-old rats, where bands at 56 and 54 kDa were detected. Binding experiments carried out on membrane preparations obtained from baculovirus-infected Sf9 cells demonstrated that the immunogenic sequence was still accessible to the antibody when the receptor was embedded in the cell membrane. Immunohistochemical studies carried out on both transfected CHO cells and infected Sf9 cells confirmed this interpretation and further indicated that the antibody could be applied in the visualization of the receptor.
Boudin
H
H
Institut National de la Santé et de la Recherche Médicale, Unité 339, Hôpital St Antoine, Paris, France.
Grauz-Guyon
A
A
Faure
M P
MP
Forgez
P
P
Lhiaubet
A M
AM
Dennis
M
M
Beaudet
A
A
Rostene
W
W
Pelaprat
D
D
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D016367:Baculoviridae / Q000737:chemistry; D001921:Brain / Q000502:physiology* / Q000648:ultrastructure*; D016466:CHO Cells / Q000378:metabolism / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism; D002540:Cerebral Cortex / Q000502:physiology / Q000648:ultrastructure; D003001:Cloning, Molecular; D006224:Cricetinae; D007150:Immunohistochemistry; D007313:Insecta / Q000166:cytology / Q000378:metabolism / Q000502:physiology; D007457:Iodine Radioisotopes; D007536:Isomerism; D008969:Molecular Sequence Data; D009496:Neurotensin / Q000378:metabolism; D010446:Peptide Fragments / Q000276:immunology; D011817:Rabbits; D051381:Rats; D018028:Receptors, Neurotensin / Q000032:analysis* / Q000276:immunology* / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000032:analysis / Q000235:genetics / Q000276:immunology; D014162:Transfection
D000906:Antibodies; D007457:Iodine Radioisotopes; D010446:Peptide Fragments; D018028:Receptors, Neurotensin; D011993:Recombinant Fusion Proteins; D009496:Neurotensin